![Tomoko Maeda-Chubachi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tomoko Maeda-Chubachi worked as a Senior Medical Director at GSK Plc from 2014 to 2017.
She then worked as the Chief Medical Officer at NVN Liquidation, Inc. from 2021 to 2023.
Dr. Maeda-Chubachi holds a doctorate degree from Osaka University and an MBA from the University of Phoenix.
Anciens postes connus de Tomoko Maeda-Chubachi
| Sociétés | Poste | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Directeur Technique/Scientifique/R&D | 27/09/2023 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/08/2017 |
Formation de Tomoko Maeda-Chubachi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
